Medical diagnostics market: Progress Alternatives led by 3M Co. and Abbott Laboratories

NEW YORK, Dec. 6, 2022 /PRNewswire/ — The medical diagnostics market measurement is forecast to develop by USD 74.58 billion at a CAGR of 6.15% between 2022 and 2027. The expansion of the market shall be pushed by the excessive prevalence of infectious illnesses. Moreover, the worldwide adoption of superior diagnostic options will foster the expansion of the market.

The report extensively covers the medical diagnostics market segmentation by kind (IVD and diagnostic imaging), end-user (hospitals and clinics, diagnostic facilities, analysis laboratories and institutes, and others), and geography (North America, Asia, Europe, and the Remainder of the World (ROW)). Request A Pattern Report

Medical diagnostics market – Distributors

The rising competitors available in the market is compelling distributors to undertake varied progress methods comparable to promotional actions and spending on ads to enhance the visibility of their providers. Some distributors are additionally adopting inorganic progress methods comparable to M&As to stay aggressive available in the market.   

• 3M Co.
• Agilent Applied sciences Inc.
• Becton Dickinson & Co.
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Charles River Laboratories
• Danaher Corp.
• DiaSorin SpA
• F. Hoffmann La Roche Ltd.
• Normal Electrical Co.
• Hologic Inc.
• Medtronic Plc
• QIAGEN NV
• Quest Diagnostics Inc.
• Quidel Corp.

Product Insights and Information

• 3M Co.: The corporate presents medical diagnostics comparable to 3M Hydrophilic Movies, 3M Substrates and Movies, and 3M Adhesive, and Spacer Tapes.
• Agilent Applied sciences Inc.: The corporate presents medical diagnostics comparable to HER2 IQFISH pharmDx, PD L1 IHC 22C3 pharmDx, and PD L1 IHC 28-8 pharmDx.
• Bio-Rad Laboratories Inc.: The corporate presents medical diagnostics comparable to Blood Group Serology Testing, Hb Variants and Genetic Issues, and Infectious Illness Testing.
• bioMerieux SA: The corporate presents medical diagnostics comparable to Emag and biofire filmarray.

For detailed insights about product choices and the expansion methods adopted by distributors, purchase the report.

Medical diagnostics market – Geographical Panorama

Asia is estimated to contribute to 38% of the market progress by 2027. The expansion of the regional market is pushed by varied components comparable to rising healthcare expenditures, elevated growing old and continual prevalent inhabitants, and rising developments towards POC, medical chemistry and molecular diagnostic instruments. Additionally, the rising prevalence of microsporidia an infection within the geriatric inhabitants and the excessive choice towards technology-integrated medical diagnostics and POC gadgets are contributing to the expansion of the medical diagnostics market in Asia.

 Medical diagnostics market – Market Segmentation

The IVD section is estimated to contribute considerably to the worldwide market’s progress in the course of the forecast interval. The section is pushed by the rising significance of molecular, medical, and immunoassay diagnostic methods. Additionally, the rising want for improved real-time diagnostic instruments for the early analysis of communicable and continual illnesses is contributing to the expansion of the section. – Obtain a pattern report

What are the important thing knowledge coated on this medical diagnostics market report?

• CAGR of the market in the course of the forecast interval.
• Detailed info on components that can drive the expansion of the market between 2023 and 2027
• Exact estimation of the medical diagnostics market measurement and its contribution to the mum or dad market.
• Correct predictions about upcoming developments and adjustments in shopper conduct.
• Progress of the business throughout North America, Asia, Europe, and the Remainder of the World (ROW).
• Thorough evaluation of the market’s aggressive panorama and detailed details about distributors.
• Complete evaluation of things that can problem the expansion of medical diagnostics market distributors.

Technavio’s library contains over 17,000+ studies, protecting greater than 2,000 rising applied sciences. Subscribe to our “Fundamental Plan” at simply USD 5,000 and get lifetime entry to Technavio Insights

Associated Experiences:

• The coronary heart assault diagnostics market measurement is anticipated to extend by USD 5.34 billion from 2021 to 2026, and the market’s progress momentum will speed up at a CAGR of seven.51%. The rising prevalence of cardiac issues is notably driving the center assault diagnostics market progress, though components comparable to pricing stress among the many distributors might impede the market progress.
• The in-vitro diagnostics market is projected to develop by USD 33.16 billion with a CAGR of 6.89% in the course of the forecast interval 2021 to 2026. The rising geriatric inhabitants with continual and infectious illnesses is likely one of the key drivers supporting the in-vitro diagnostics market progress.

Desk of contents:

1 Govt Abstract

• 1.1 Market overview 
• Exhibit 01: Govt Abstract – Chart on Market Overview
• Exhibit 02: Govt Abstract – Knowledge Desk on Market Overview
• Exhibit 03: Govt Abstract – Chart on World Market Traits
• Exhibit 04: Govt Abstract – Chart on Market by Geography
• Exhibit 05: Govt Abstract – Chart on Market Segmentation by Sort
• Exhibit 06: Govt Abstract – Chart on Market Segmentation by Finish-user
• Exhibit 07: Govt Abstract – Chart on Incremental Progress
• Exhibit 08: Govt Abstract – Knowledge Desk on Incremental Progress
• Exhibit 09: Govt Abstract – Chart on Vendor Market Positioning

2 Market Panorama

• 2.1 Market ecosystem 
• Exhibit 10: Guardian market
• Exhibit 11: Market Traits

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Choices of distributors included available in the market definition

• 3.2 Market section evaluation 
• Exhibit 13: Market segments

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on World – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 15: Knowledge Desk on World – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on World Market: Yr-over-year progress 2022-2027 (%)
• Exhibit 17: Knowledge Desk on World Market: Yr-over-year progress 2022-2027 (%)

4 Historic Market Dimension

• 4.1 World medical diagnostics market 2017 – 2021
• Exhibit 18: Historic Market Dimension – Knowledge Desk on World medical diagnostics market 2017 – 2021 ($ billion)

• 4.2 Sort Phase Evaluation 2017 – 2021 
• Exhibit 19: Historic Market Dimension – Sort Phase 2017 – 2021 ($ billion)

• 4.3 Finish-user Phase Evaluation 2017 – 2021 
• Exhibit 20: Historic Market Dimension – Finish-user Phase 2017 – 2021 ($ billion)

• 4.4 Geography Phase Evaluation 2017 – 2021 
• Exhibit 21: Historic Market Dimension – Geography Phase 2017 – 2021 ($ billion)

• 4.5 Nation Phase Evaluation 2017 – 2021 
• Exhibit 22: Historic Market Dimension – Nation Phase 2017 – 2021 ($ billion)

5 5 Forces Evaluation

• 5.1 5 forces abstract 
• Exhibit 23: 5 forces evaluation – Comparability between 2022 and 2027

• 5.2 Bargaining energy of consumers 
• Exhibit 24: Chart on Bargaining energy of consumers – Influence of key components 2022 and 2027

• 5.3 Bargaining energy of suppliers 
• Exhibit 25: Bargaining energy of suppliers – Influence of key components in 2022 and 2027

• 5.4 Risk of latest entrants 
• Exhibit 26: Risk of latest entrants – Influence of key components in 2022 and 2027

• 5.5 Risk of substitutes 
• Exhibit 27: Risk of substitutes – Influence of key components in 2022 and 2027

• 5.6 Risk of rivalry 
• Exhibit 28: Risk of rivalry – Influence of key components in 2022 and 2027

• 5.7 Market situation 
• Exhibit 29: Chart on Market situation – 5 forces 2022 and 2027

6 Market Segmentation by Sort

• 6.1 Market segments 
• Exhibit 30: Chart on Sort – Market share 2022-2027 (%)
• Exhibit 31: Knowledge Desk on Sort – Market share 2022-2027 (%)

• 6.2 Comparability by Sort 
• Exhibit 32: Chart on Comparability by Sort
• Exhibit 33: Knowledge Desk on Comparability by Sort

• 6.3 IVD – Market measurement and forecast 2022-2027
• Exhibit 34: Chart on IVD – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 35: Knowledge Desk on IVD – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on IVD – Yr-over-year progress 2022-2027 (%)
• Exhibit 37: Knowledge Desk on IVD – Yr-over-year progress 2022-2027 (%)

• 6.4 Diagnostic imaging – Market measurement and forecast 2022-2027
• Exhibit 38: Chart on Diagnostic imaging – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 39: Knowledge Desk on Diagnostic imaging – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Diagnostic imaging – Yr-over-year progress 2022-2027 (%)
• Exhibit 41: Knowledge Desk on Diagnostic imaging – Yr-over-year progress 2022-2027 (%)

• 6.5 Market alternative by Sort 
• Exhibit 42: Market alternative by Sort ($ billion)

7 Market Segmentation by Finish-user

• 7.1 Market segments 
• Exhibit 43: Chart on Finish-user – Market share 2022-2027 (%)
• Exhibit 44: Knowledge Desk on Finish-user – Market share 2022-2027 (%)

• 7.2 Comparability by Finish-user 
• Exhibit 45: Chart on Comparability by Finish-user
• Exhibit 46: Knowledge Desk on Comparability by Finish-user

• 7.3 Hospitals and clinics – Market measurement and forecast 2022-2027 
• Exhibit 47: Chart on Hospitals and clinics – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 48: Knowledge Desk on Hospitals and clinics – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 49: Chart on Hospitals and clinics – Yr-over-year progress 2022-2027 (%)
• Exhibit 50: Knowledge Desk on Hospitals and clinics – Yr-over-year progress 2022-2027 (%)

• 7.4 Diagnostic facilities – Market measurement and forecast 2022-2027
• Exhibit 51: Chart on Diagnostic facilities – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 52: Knowledge Desk on Diagnostic facilities – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 53: Chart on Diagnostic facilities – Yr-over-year progress 2022-2027 (%)
• Exhibit 54: Knowledge Desk on Diagnostic facilities – Yr-over-year progress 2022-2027 (%)

• 7.5 Analysis laboratories and institutes – Market measurement and forecast 2022-2027 
• Exhibit 55: Chart on Analysis laboratories and institutes – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 56: Knowledge Desk on Analysis laboratories and institutes – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 57: Chart on Analysis laboratories and institutes – Yr-over-year progress 2022-2027 (%)
• Exhibit 58: Knowledge Desk on Analysis laboratories and institutes – Yr-over-year progress 2022-2027 (%)

• 7.6 Others – Market measurement and forecast 2022-2027
• Exhibit 59: Chart on Others – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 60: Knowledge Desk on Others – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 61: Chart on Others – Yr-over-year progress 2022-2027 (%)
• Exhibit 62: Knowledge Desk on Others – Yr-over-year progress 2022-2027 (%)

• 7.7 Market alternative by Finish-user 
• Exhibit 63: Market alternative by Finish-user ($ billion)

8 Buyer Panorama

• 8.1 Buyer panorama overview 
• Exhibit 64: Evaluation of value sensitivity, lifecycle, buyer buy basket, adoption charges, and buy standards

9 Geographic Panorama

• 9.1 Geographic segmentation 
• Exhibit 65: Chart on Market share by geography 2022-2027 (%)
• Exhibit 66: Knowledge Desk on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparability 
• Exhibit 67: Chart on Geographic comparability
• Exhibit 68: Knowledge Desk on Geographic comparability

• 9.3 North America – Market measurement and forecast 2022-2027
• Exhibit 69: Chart on North America – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 70: Knowledge Desk on North America – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 71: Chart on North America – Yr-over-year progress 2022-2027 (%)
• Exhibit 72: Knowledge Desk on North America – Yr-over-year progress 2022-2027 (%)

• 9.4 Asia – Market measurement and forecast 2022-2027
• Exhibit 73: Chart on Asia – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 74: Knowledge Desk on Asia – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 75: Chart on Asia – Yr-over-year progress 2022-2027 (%)
• Exhibit 76: Knowledge Desk on Asia – Yr-over-year progress 2022-2027 (%)

• 9.5 Europe – Market measurement and forecast 2022-2027
• Exhibit 77: Chart on Europe – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 78: Knowledge Desk on Europe – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 79: Chart on Europe – Yr-over-year progress 2022-2027 (%)
• Exhibit 80: Knowledge Desk on Europe – Yr-over-year progress 2022-2027 (%)

• 9.6 Remainder of World (ROW) – Market measurement and forecast 2022-2027
• Exhibit 81: Chart on Remainder of World (ROW) – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 82: Knowledge Desk on Remainder of World (ROW) – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 83: Chart on Remainder of World (ROW) – Yr-over-year progress 2022-2027 (%)
• Exhibit 84: Knowledge Desk on Remainder of World (ROW) – Yr-over-year progress 2022-2027 (%)

• 9.7 US – Market measurement and forecast 2022-2027
• Exhibit 85: Chart on US – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 86: Knowledge Desk on US – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 87: Chart on US – Yr-over-year progress 2022-2027 (%)
• Exhibit 88: Knowledge Desk on US – Yr-over-year progress 2022-2027 (%)

• 9.8 China – Market measurement and forecast 2022-2027
• Exhibit 89: Chart on China – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 90: Knowledge Desk on China – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 91: Chart on China – Yr-over-year progress 2022-2027 (%)
• Exhibit 92: Knowledge Desk on China – Yr-over-year progress 2022-2027 (%)

• 9.9 Japan – Market measurement and forecast 2022-2027
• Exhibit 93: Chart on Japan – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 94: Knowledge Desk on Japan – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 95: Chart on Japan – Yr-over-year progress 2022-2027 (%)
• Exhibit 96: Knowledge Desk on Japan – Yr-over-year progress 2022-2027 (%)

• 9.10 Germany – Market measurement and forecast 2022-2027
• Exhibit 97: Chart on Germany – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 98: Knowledge Desk on Germany – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 99: Chart on Germany – Yr-over-year progress 2022-2027 (%)
• Exhibit 100: Knowledge Desk on Germany – Yr-over-year progress 2022-2027 (%)

• 9.11 UK – Market measurement and forecast 2022-2027
• Exhibit 101: Chart on UK – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 102: Knowledge Desk on UK – Market measurement and forecast 2022-2027 ($ billion)
• Exhibit 103: Chart on UK – Yr-over-year progress 2022-2027 (%)
• Exhibit 104: Knowledge Desk on UK – Yr-over-year progress 2022-2027 (%)

• 9.12 Market alternative by geography 
• Exhibit 105: Market alternative by geography ($ billion)

10 Drivers, Challenges, and Tendencies

• 10.3 Influence of drivers and challenges 
• Exhibit 106: Influence of drivers and challenges in 2022 and 2027

11 Vendor Panorama

• 11.2 Vendor panorama 
• Exhibit 107: Overview on Criticality of inputs and Elements of differentiation

• 11.3 Panorama disruption 
• Exhibit 108: Overview on components of disruption

• 11.4 Business dangers 
• Exhibit 109: Influence of key dangers on enterprise

12 Vendor Evaluation

• 12.1 Distributors coated 
• Exhibit 110: Distributors coated

• 12.2 Market positioning of distributors 
• Exhibit 111: Matrix on vendor place and classification

• 12.3 3M Co. 
• Exhibit 112: 3M Co. – Overview
• Exhibit 113: 3M Co. – Enterprise segments
• Exhibit 114: 3M Co. – Key information
• Exhibit 115: 3M Co. – Key choices
• Exhibit 116: 3M Co. – Phase focus

• 12.4 Abbott Laboratories 
• Exhibit 117: Abbott Laboratories – Overview
• Exhibit 118: Abbott Laboratories – Enterprise segments
• Exhibit 119: Abbott Laboratories – Key information
• Exhibit 120: Abbott Laboratories – Key choices
• Exhibit 121: Abbott Laboratories – Phase focus

• 12.5 Agilent Applied sciences Inc. 
• Exhibit 122: Agilent Applied sciences Inc. – Overview
• Exhibit 123: Agilent Applied sciences Inc. – Enterprise segments
• Exhibit 124: Agilent Applied sciences Inc. – Key information
• Exhibit 125: Agilent Applied sciences Inc. – Key choices
• Exhibit 126: Agilent Applied sciences Inc. – Phase focus

• 12.6 Bio Rad Laboratories Inc. 
• Exhibit 127: Bio Rad Laboratories Inc. – Overview
• Exhibit 128: Bio Rad Laboratories Inc. – Enterprise segments
• Exhibit 129: Bio Rad Laboratories Inc. – Key information
• Exhibit 130: Bio Rad Laboratories Inc. – Key choices
• Exhibit 131: Bio Rad Laboratories Inc. – Phase focus

• 12.7 bioMerieux SA 
• Exhibit 132: bioMerieux SA – Overview
• Exhibit 133: bioMerieux SA – Product / Service
• Exhibit 134: bioMerieux SA – Key choices

• 12.8 Charles River Laboratories 
• Exhibit 135: Charles River Laboratories – Overview
• Exhibit 136: Charles River Laboratories – Enterprise segments
• Exhibit 137: Charles River Laboratories – Key information
• Exhibit 138: Charles River Laboratories – Key choices
• Exhibit 139: Charles River Laboratories – Phase focus

• 12.9 Danaher Corp. 
• Exhibit 140: Danaher Corp. – Overview
• Exhibit 141: Danaher Corp. – Enterprise segments
• Exhibit 142: Danaher Corp. – Key information
• Exhibit 143: Danaher Corp. – Key choices
• Exhibit 144: Danaher Corp. – Phase focus

• 12.10 DiaSorin SpA 
• Exhibit 145: DiaSorin SpA – Overview
• Exhibit 146: DiaSorin SpA – Enterprise segments
• Exhibit 147: DiaSorin SpA – Key information
• Exhibit 148: DiaSorin SpA – Key choices
• Exhibit 149: DiaSorin SpA – Phase focus

• 12.11 F. Hoffmann La Roche Ltd. 
• Exhibit 150: F. Hoffmann La Roche Ltd. – Overview
• Exhibit 151: F. Hoffmann La Roche Ltd. – Enterprise segments
• Exhibit 152: F. Hoffmann La Roche Ltd. – Key information
• Exhibit 153: F. Hoffmann La Roche Ltd. – Key choices
• Exhibit 154: F. Hoffmann La Roche Ltd. – Phase focus

• 12.12 Normal Electrical Co. 
• Exhibit 155: Normal Electrical Co. – Overview
• Exhibit 156: Normal Electrical Co. – Enterprise segments
• Exhibit 157: Normal Electrical Co. – Key information
• Exhibit 158: Normal Electrical Co. – Key choices
• Exhibit 159: Normal Electrical Co. – Phase focus

• 12.13 Hologic Inc. 
• Exhibit 160: Hologic Inc. – Overview
• Exhibit 161: Hologic Inc. – Enterprise segments
• Exhibit 162: Hologic Inc. – Key information
• Exhibit 163: Hologic Inc. – Key choices
• Exhibit 164: Hologic Inc. – Phase focus

• 12.14 QIAGEN NV 
• Exhibit 165: QIAGEN NV – Overview
• Exhibit 166: QIAGEN NV – Product / Service
• Exhibit 167: QIAGEN NV – Key information
• Exhibit 168: QIAGEN NV – Key choices

• 12.15 Quest Diagnostics Inc. 
• Exhibit 169: Quest Diagnostics Inc. – Overview
• Exhibit 170: Quest Diagnostics Inc. – Enterprise segments
• Exhibit 171: Quest Diagnostics Inc. – Key choices
• Exhibit 172: Quest Diagnostics Inc. – Phase focus

• 12.16 Siemens AG 
• Exhibit 173: Siemens AG – Overview
• Exhibit 174: Siemens AG – Enterprise segments
• Exhibit 175: Siemens AG – Key information
• Exhibit 176: Siemens AG – Key choices
• Exhibit 177: Siemens AG – Phase focus

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 178: Thermo Fisher Scientific Inc. – Overview
• Exhibit 179: Thermo Fisher Scientific Inc. – Enterprise segments
• Exhibit 180: Thermo Fisher Scientific Inc. – Key information
• Exhibit 181: Thermo Fisher Scientific Inc. – Key choices
• Exhibit 182: Thermo Fisher Scientific Inc. – Phase focus

13 Appendix

• 13.2 Inclusions and exclusions guidelines 
• Exhibit 183: Inclusions guidelines
• Exhibit 184: Exclusions guidelines

• 13.3 Foreign money conversion charges for US$ 
• Exhibit 185: Foreign money conversion charges for US$

• 13.4 Analysis methodology 
• Exhibit 186: Analysis methodology
• Exhibit 187: Validation methods employed for market sizing
• Exhibit 188: Data sources

• 13.5 Checklist of abbreviations 
• Exhibit 189: Checklist of abbreviations

About Technavio

Technavio is a number one world know-how analysis and advisory firm. Their analysis and evaluation deal with rising market developments and gives actionable insights to assist companies establish market alternatives and develop efficient methods to optimize their market positions.

With over 500 specialised analysts, Technavio’s report library consists of greater than 17,000 studies and counting, protecting 800 applied sciences, spanning throughout 50 international locations. Their consumer base consists of enterprises of all sizes, together with greater than 100 Fortune 500 corporations. This rising consumer base depends on Technavio’s complete protection, intensive analysis, and actionable market insights to establish alternatives in current and potential markets and assess their aggressive positions inside altering market eventualities.

Contacts

Technavio Analysis
Jesse Maida
Media & Advertising Govt
US: +1 844 364 1100
UK: +44 203 893 3200
Electronic mail: [email protected]
Web site: www.technavio.com/

SOURCE Technavio